by Brent Vandermeer | Dec 7, 2020 | Market Commentary
November 2020 Vaccine Relief Rally In a remarkably short time, three pharmaceutical heavyweights (Pfizer, Moderna, and AstraZeneca) have announced they’re nearing the final stages of developing a COVID-19 vaccine. The surprisingly high effectiveness of some of the...
by Brent Vandermeer | Nov 5, 2020 | Market Commentary
October 2020 Canada’s Future Growth Throughout October, investors took positions to de-risk portfolios in the run-up to the U.S. Presidential election. This de-risking, coupled with rising COVID infections and new lockdowns in Europe, resulted in the S&P/TSX and...
by Brent Vandermeer | Oct 6, 2020 | Market Commentary
September 2020 The Economy Takes on a New Shape As lockdown restrictions eased, a second wave of COVID cases surged across Europe and India. As a result, mobility-tracking data produced by Google and Apple shows people are willingly travelling less in these regions,...
by Brent Vandermeer | Sep 10, 2020 | Market Commentary
August 2020 RECOVERY CONTINUES Over the early summer months, global economies have shown improvements. Jobs, retail sales, food services, and industrial production have been experiencing significant bounces. As we head into the fall, the recovery is expected to...
by Brent Vandermeer | Aug 12, 2020 | Market Commentary
July 2020 UNEVEN RECOVERY The theme of July was strong growth in risk assets compared to a weak US dollar. Relative to history, the US dollar had the worst month of all the major asset classes. A weak US dollar helps spur growth because it lowers the cost of buying US...
by Brent Vandermeer | Jul 10, 2020 | Market Commentary
June 2020 Has The Stock Market Moved On From COVID-19? Ending a quarter of strong recovery from March-lows, the S&P 500 was up 1.8% and the S&P/TSX Composite up 2.1%, in their respective local currencies. Year-to-date, the S&P/TSX Composite has struggled...
